Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for EVOTF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
June 30, 2026 -1.10%
March 31, 2026 -1.00%
December 31, 2025 30.98%
September 30, 2025 -0.04%
June 30, 2025 5.02%
March 31, 2025 13.61%
December 31, 2024 20.84%
September 30, 2024 9.89%
June 30, 2024 8.64%
March 31, 2024 16.65%
December 31, 2023 18.71%
September 30, 2023 19.27%
June 30, 2023 27.20%
March 31, 2023 24.93%
December 31, 2022 34.26%
September 30, 2022 16.34%
June 30, 2022 17.94%
March 31, 2022 19.61%
December 31, 2021 27.84%
September 30, 2021 27.04%
June 30, 2021 18.54%
March 31, 2021 23.05%
December 31, 2020 26.02%
September 30, 2020 27.91%
June 30, 2020 17.74%
Date Value
March 31, 2020 27.87%
December 31, 2019 27.25%
September 30, 2019 30.64%
June 30, 2019 31.14%
March 31, 2019 30.48%
December 31, 2018 26.88%
September 30, 2018 34.70%
June 30, 2018 33.56%
March 31, 2018 22.65%
December 31, 2017 23.98%
September 30, 2017 33.43%
June 30, 2017 34.11%
March 31, 2017 37.31%
December 31, 2016 27.71%
September 30, 2016 45.14%
June 30, 2016 35.64%
March 31, 2016 33.27%
December 31, 2015 28.19%
September 30, 2015 29.16%
June 30, 2015 24.74%
March 31, 2015 28.02%
December 31, 2014 39.77%
September 30, 2014 22.94%
June 30, 2014 29.30%
March 31, 2014 21.88%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Sartorius AG 47.50%
SCHOTT Pharma AG & Co. KGaA 30.66%
Agilent Technologies, Inc. 56.60%
Bio-Rad Laboratories, Inc. 53.12%
Bruker Corp. 49.65%

Gross Profit Margin (Quarterly) Related Metrics